Arena Pharmaceuticals, Inc. Restricted Cash
Arena Pharmaceuticals, Inc. had Restricted Cash of $226.00 thousand as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2022-02-23
- 2021-12-31: Restricted Cash $226.00K.
- 2021-09-30: Restricted Cash $226.00K.
- 2021-06-30: Restricted Cash $226.00K.
- 2021-03-31: Restricted Cash $226.00K.
| Period end | Restricted Cash |
|---|---|
| 2021-12-31 | $226.00K 10-K · filed 2022-02-23 |
| 2021-09-30 | $226.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $226.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $226.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $226.00K 10-K · filed 2022-02-23 |
| 2020-09-30 | $226.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $226.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $226.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $226.00K 10-K · filed 2021-02-23 |
| 2019-09-30 | $226.00K 10-Q · filed 2019-11-08 |
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $863.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $863.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $863.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $863.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $863.00K 10-K · filed 2019-02-28 |